Dr Muralidhar Gullipalli – Medical Oncologist
Dr. Muralidhar Gullipalli is a renowned Medical Oncologist with 19 years of experience, currently affiliated with Medicover Hospital in Kakinada. Throughout his career, he has provided expert oncology care in various cities across India. His extensive experience includes diagnosing and treating a wide range of cancers, employing the latest advancements in medical oncology. Dr. Gullipalli is well-regarded for his patient-centered approach and dedication to oncology research and education. His commitment to the field has made him a respected figure in the medical community.
Specializations
Dr. Muralidhar Gullipalli performs major interventions in the following specialties –
- Medical Oncology
Expertise
Dr. Muralidhar Gullipalli has expertization in the following areas –
- Breast and Lung cancer
- Gastro intestinal
- Genito urinary
- Leukemias and Lymphomas
- Autologus Bone marrow transplant
- Blood Cancer
- Pediatric cancer
- Sarcoma Cancer
- GI Cancer
- Bone marrow Transplant
Education & Achievements
- Dr YSR University Of Health Sciences (MBBS )
- MD General Medicine
- DM Medical Oncology
Work Experience
- Consultant – Medicover Hospital, Kakinada
Treatments
Dr. Muralidhar Gullipalli specializes in the following treatments:
Publications
Dr. Muralidhar Gullipalli has authored many publications including –
- Kota R, Gundeti S, Gullipalli M, Linga VG, Maddali LS, Digumarti R. Prevalence and outcome of epidermal growth factor receptor mutations in non-squamous non-small cell lung cancer patients. Lung India 2015;32:561-5.
- Outcomes of Ewing’s sarcoma: Real-world scenario from the developing world—An 11-year analysis.
- Outcomes in pediatric CML in a developing country: Beyond the disease biology
- Outcomes of Ewing’s sarcoma: Real-world scenario from the developing world—An 11-year analysis.
- Outcomes in pediatric CML in a developing country: Beyond the disease biology.
- Clinical Profile and Outcome of Pediatric Acute Myeloid Leukemias
- Prostatic Non-Hodgkin Lymphoma—A Rare Case Report
- Is It End Of Clinical Autopsy Or Could It Be Replaced With Minimal Invasive Procedures
- Imatinib dose hike in suboptimal response and failure in CML CP: Results from a developing nation.
- Factors predicting the outcome in febrile neutropenia: A study from a tertiary cancer center in India.
Languages
- English
- Telugu
- Hindi